384 related articles for article (PubMed ID: 17019564)
1. Lower striatal dopamine transporter binding in neuroleptic-naive schizophrenic patients is not related to antipsychotic treatment but it suggests an illness trait.
Mateos JJ; Lomeña F; Parellada E; Mireia F; Fernandez-Egea E; Pavia J; Prats A; Pons F; Bernardo M
Psychopharmacology (Berl); 2007 Apr; 191(3):805-11. PubMed ID: 17019564
[TBL] [Abstract][Full Text] [Related]
2. Decreased striatal dopamine transporter binding assessed with [123I] FP-CIT in first-episode schizophrenic patients with and without short-term antipsychotic-induced parkinsonism.
Mateos JJ; Lomeña F; Parellada E; Font M; Fernandez E; Pavia J; Prats A; Pons F; Bernardo M
Psychopharmacology (Berl); 2005 Sep; 181(2):401-6. PubMed ID: 15830229
[TBL] [Abstract][Full Text] [Related]
3. [Striatal dopamine transporter density decrease in first episode schizophrenic patients treated with risperidone].
Mateos JJ; Lomeña F; Parellada E; Font M; Fernández E; Pavia J; Prats A; Bernardo M
Rev Esp Med Nucl; 2006; 25(3):159-65. PubMed ID: 16762269
[TBL] [Abstract][Full Text] [Related]
4. Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study.
Tinazzi M; Morgante F; Matinella A; Bovi T; Cannas A; Solla P; Marrosu F; Nicoletti A; Zappia M; Luca A; Di Stefano A; Morgante L; Pacchetti C; Minafra B; Sciarretta M; Dallocchio C; Rossi S; Ulivelli M; Ceravolo R; Frosini D; Cipriani A; Barbui C
Schizophr Res; 2014 Feb; 152(2-3):344-9. PubMed ID: 24369987
[TBL] [Abstract][Full Text] [Related]
5. Early-onset drug-induced parkinsonism after exposure to offenders implies nigrostriatal dopaminergic dysfunction.
Chung SJ; Yoo HS; Moon H; Oh JS; Kim JS; Park YH; Hong JY; Ye BS; Sohn YH; Lee PH
J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):169-174. PubMed ID: 28912301
[TBL] [Abstract][Full Text] [Related]
6. Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: a 123I-FP-CIT SPECT study.
Roselli F; Pisciotta NM; Perneczky R; Pennelli M; Aniello MS; De Caro MF; Ferrannini E; Tartaglione B; Defazio G; Rubini G; Livrea P
Mov Disord; 2009 Oct; 24(14):2097-103. PubMed ID: 19705471
[TBL] [Abstract][Full Text] [Related]
7. Striatal dopamine transporter availability is associated with the productive psychotic state in first episode, drug-naive schizophrenic patients.
Schmitt GJ; Frodl T; Dresel S; la Fougère C; Bottlender R; Koutsouleris N; Hahn K; Möller HJ; Meisenzahl EM
Eur Arch Psychiatry Clin Neurosci; 2006 Mar; 256(2):115-21. PubMed ID: 16284713
[TBL] [Abstract][Full Text] [Related]
8. Measurement of [123I]FP-CIT binding to the dopamine transporter (DAT) in healthy mouse striatum using dedicated small animal SPECT imaging: feasibility, optimization and validation.
Greco A; Zannetti A; Pappatà S; Albanese S; Coda AR; Ragucci M; Nardelli A; Brunetti A; Cuocolo A; Salvatore M
Q J Nucl Med Mol Imaging; 2018 Mar; 62(1):112-117. PubMed ID: 26329495
[TBL] [Abstract][Full Text] [Related]
9. Unaltered Dopamine Transporter Availability in Drug-Naive Patients With Schizophrenia After 6 Months of Antipsychotics Treatment: A Naturalistic Study.
Chang WH; Chen KC; Lee IH; Chi MH; Chen PS; Yao WJ; Chiu NT; Yang YK
J Clin Psychopharmacol; 2017 Feb; 37(1):21-26. PubMed ID: 28027110
[TBL] [Abstract][Full Text] [Related]
10. The striatal dopamine transporter in first-episode, drug-naive schizophrenic patients: evaluation by the new SPECT-ligand[99mTc]TRODAT-1.
Schmitt GJ; Meisenzahl EM; Frodl T; La Fougère C; Hahn K; Möller HJ; Dresel S
J Psychopharmacol; 2005 Sep; 19(5):488-93. PubMed ID: 16166186
[TBL] [Abstract][Full Text] [Related]
11. A 4-year dopamine transporter (DAT) imaging study in neuroleptic-naive first episode schizophrenia patients.
Mané A; Gallego J; Lomeña F; Mateos JJ; Fernandez-Egea E; Horga G; Cot A; Pavia J; Bernardo M; Parellada E
Psychiatry Res; 2011 Oct; 194(1):79-84. PubMed ID: 21831607
[TBL] [Abstract][Full Text] [Related]
12. Dual-isotope SPECT imaging of striatal dopamine: first episode, drug naïve schizophrenic patients.
Schmitt GJ; la Fougère C; Dresel S; Frodl T; Hahn K; Möller HJ; Meisenzahl EM
Schizophr Res; 2008 Apr; 101(1-3):133-41. PubMed ID: 18083348
[TBL] [Abstract][Full Text] [Related]
13. Quantitative evaluation of striatal I-123-FP-CIT uptake in essential tremor and parkinsonism.
Cuberas-Borrós G; Lorenzo-Bosquet C; Aguadé-Bruix S; Hernández-Vara J; Pifarré-Montaner P; Miquel F; Álvarez-Sabin J; Castell-Conesa J
Clin Nucl Med; 2011 Nov; 36(11):991-6. PubMed ID: 21975386
[TBL] [Abstract][Full Text] [Related]
14. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M
Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
[TBL] [Abstract][Full Text] [Related]
15. [¹²³I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism.
Tinazzi M; Cipriani A; Matinella A; Cannas A; Solla P; Nicoletti A; Zappia M; Morgante L; Morgante F; Pacchetti C; Sciarretta M; Dallocchio C; Rossi S; Malentacchi M; Ceravolo R; Frosini D; Sestini S; Bovi T; Barbui C
Schizophr Res; 2012 Aug; 139(1-3):40-5. PubMed ID: 22727453
[TBL] [Abstract][Full Text] [Related]
16. Striatal dopamine D2 receptor density in neuroleptic-naive and in neuroleptic-free schizophrenic patients: an 123I-IBZM-SPECT study.
Lomeña F; Catafau AM; Parellada E; Bernardo M; Font M; Gutiérrez F; Pavía J
Psychopharmacology (Berl); 2004 Mar; 172(2):165-9. PubMed ID: 14624330
[TBL] [Abstract][Full Text] [Related]
17. Frontal D2/3 Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology.
Nørbak-Emig H; Ebdrup BH; Fagerlund B; Svarer C; Rasmussen H; Friberg L; Allerup PN; Rostrup E; Pinborg LH; Glenthøj BY
Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26819282
[TBL] [Abstract][Full Text] [Related]
18. Dual-isotope SPECT imaging of striatal dopamine: a comparative study between never-treated and haloperidol-treated first-episode schizophrenic patients.
Schmitt GJ; Dresel S; Frodl T; la Fougère C; Boerner R; Hahn K; Möller HJ; Meisenzahl EM
Eur Arch Psychiatry Clin Neurosci; 2012 Apr; 262(3):183-91. PubMed ID: 22081145
[TBL] [Abstract][Full Text] [Related]
19. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.
Lorberboym M; Djaldetti R; Melamed E; Sadeh M; Lampl Y
J Nucl Med; 2004 Oct; 45(10):1688-93. PubMed ID: 15471834
[TBL] [Abstract][Full Text] [Related]
20. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.
Iranzo A; Valldeoriola F; Lomeña F; Molinuevo JL; Serradell M; Salamero M; Cot A; Ros D; Pavía J; Santamaria J; Tolosa E
Lancet Neurol; 2011 Sep; 10(9):797-805. PubMed ID: 21802993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
